drugset / Trial / NCT02807428

Study to Evaluate Safety/Efficacy of a Single Preop Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery

NCT02807428 ↗

Phase 2 Completed 210 enrolled Adynxx, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The objectives of this study are to evaluate the safety and analgesic efficacy of a single preoperative intrathecal administration of AYX1 Injection in patients undergoing unilateral total knee arthroplasty.

Timeline

Start
2017-02-20
Primary completion
2017-10-23
Completion
2017-12-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Brivoligide Unknown 660 mg Intrathecal

Indications

No indication recorded.